BMP4 and BMP antagonists regulate human white and beige adipogenesis

Diabetes

Volumn 64, Issue 5, 2015, Pages 1670-1681

  Gustafson, Birgit ^a   Hammarstedt, Ann ^a   Hedjazifar, Shahram ^a   Hoffmann, Jenny M ^a   Svensson, Per Arne ^a   Grimsby, Joseph ^b   Rondinone, Cristina ^b   Smith, Ulf ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; GREMLIN 1; OSTEOGENIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PROTEIN INHIBITOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; BMP4 PROTEIN, HUMAN; CHRDL1 PROTEIN, HUMAN; EYE PROTEIN; GREM1 PROTEIN, HUMAN; NERVE PROTEIN; SIGNAL PEPTIDE;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE CELL; ADULT; ARTICLE; BARIATRIC SURGERY; BEIGE ADIPOGENESIS; BROWN ADIPOSE TISSUE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEEDBACK SYSTEM; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MITOCHONDRION; MULTIPOTENT STEM CELL; NEEDLE BIOPSY; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; TRANSCRIPTION INITIATION; WHITE ADIPOGENESIS; WHITE ADIPOSE TISSUE; ADIPOSE TISSUE; ANTAGONISTS AND INHIBITORS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RNA INTERFERENCE;

ADIPOGENESIS; ADIPOSE TISSUE; ADIPOSE TISSUE, BROWN; ADULT; BONE MORPHOGENETIC PROTEIN 4; EYE PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; OBESITY; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84929657663     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1127     Document Type: Article

References (49)

1. Neeland IJ, Turer AT, Ayers CR, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012;308:1150-1159.
2. Gallagher D, Kelley DE, Yim JE, et al.; MRI Ancillary Study Group of the Look AHEAD Research Group. Adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr 2009;89:807-814.
3. Gastaldelli A, Harrison SA, Belfort-Aguilar R, et al. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology 2009;50: 1087-1093.
4. Arner E, Westermark PO, Spalding KL, et al. Adipocyte turnover: Relevance to human adipose tissue morphology. Diabetes 2010;59:105-109.
5. Arner P, Arner E, Hammarstedt A, Smith U. Genetic predisposition for type 2 diabetes, but not for overweight/obesity, is associated with a restricted adipogenesis. PLoS ONE 2011;6:e18284.
6. Gustafson B, Smith U. The WNT inhibitor Dickkopf 1 and bone morphogenetic protein 4 rescue adipogenesis in hypertrophic obesity in humans. Diabetes 2012;61:1217-1224.
7. Isakson P, Hammarstedt A, Gustafson B, Smith U. Impaired preadipocyte differentiation in human abdominal obesity: Role of Wnt, tumor necrosis factoralpha, and inflammation. Diabetes 2009;58:1550-1557.
8. Jansson PA, Pellmé F, Hammarstedt A, et al. A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin. FASEB J 2003;17:1434-1440.
9. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808.
10. Cederberg H, Stan-cáková A, Kuusisto J, Laakso M, Smith U. Family history of type 2 diabetes increases the risk of both obesity and its complications: is type 2 diabetes a disease of inappropriate lipid storage? J Intern Med. 12 July 2014 [Epub ahead of print].
11. Scott RA, Fall T, Pasko D, et al.; RISC Study Group; EPIC-InterAct Consortium. Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity. Diabetes 2014;63: 4378-4387.
12. Bowers RR, Kim JW, Otto TC, Lane MD. Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: Role of the BMP-4 gene. Proc Natl Acad Sci U S A 2006;103:13022-13027.
13. Bowers RR, Lane MD. A role for bone morphogenetic protein-4 in adipocyte development. Cell Cycle 2007;6:385-389.
14. Tang QQ, Otto TC, Lane MD. Commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc Natl Acad Sci U S A 2004;101:9607-9611.
15. Tseng YH, Kokkotou E, Schulz TJ, et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 2008;454: 1000-1004.
16. Gustafson B, Hammarstedt A, Hedjazifar S, Smith U. Restricted adipogenesis in hypertrophic obesity: The role of WISP2, WNT, and BMP4. Diabetes 2013;62:2997-3004.
17. Elsen M, Raschke S, Tennagels N, et al. BMP4 and BMP7 induce the whiteto- brown transition of primary human adipose stem cells. Am J Physiol Cell Physiol 2014;306:C431-C440.
18. Gupta RK, Arany Z, Seale P, et al. Transcriptional control of preadipocyte determination by Zfp423. Nature 2010;464:619-623.
19. Hammarstedt A, Hedjazifar S, Jenndahl L, et al. WISP2 regulates preadipocyte commitment and PPARg activation by BMP4. Proc Natl Acad Sci U S A 2013;110:2563-2568.
20. Gao H, Mejhert N, Fretz JA, et al. Early B cell factor 1 regulates adipocyte morphology and lipolysis in white adipose tissue. Cell Metab 2014;19:981-992.
21. Gazzerro E, Canalis E. Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 2006;7:51-65.
22. Walsh DW, Godson C, Brazil DP, Martin F. Extracellular BMP- Antagonist regulation in development and disease: Tied up in knots. Trends Cell Biol 2010; 20:244-256.
23. Zaragosi LE, Wdziekonski B, Villageois P, et al. Activin a plays a critical role in proliferation and differentiation of human adipose progenitors. Diabetes 2010; 59:2513-2521.
24. Carlsson LM, Jacobson P, Walley A, et al. ALK7 expression is specific for adipose tissue, reduced in obesity and correlates to factors implicated in metabolic disease. Biochem Biophys Res Commun 2009;382:309-314.
25. Nakatani M, Takehara Y, Sugino H, et al. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice. FASEB J 2008;22:477- 487.
26. Luo X, Hutley LJ, Webster JA, et al. Identification of BMP and activin membrane-bound inhibitor (BAMBI) as a potent negative regulator of adipogenesis and modulator of autocrine/paracrine adipogenic factors. Diabetes 2012; 61:124-136.
27. Flanagan JN, Linder K, Mejhert N, et al. Role of follistatin in promoting adipogenesis in women. J Clin Endocrinol Metab 2009;94:3003-3009.
28. Wang G, Zhang H, Zhao Y, et al. Noggin and bFGF cooperate to maintain the pluripotency of human embryonic stem cells in the absence of feeder layers. Biochem Biophys Res Commun 2005;330:934-942.
29. Zhang D, Ferguson CM, O'Keefe RJ, Puzas JE, Rosier RN, Reynolds PR. A role for the BMP antagonist chordin in endochondral ossification. J Bone Miner Res 2002;17:293-300.
30. Fernandes H, Dechering K, van Someren E, et al. Effect of chordin-like 1 on MC3T3-E1 and human mesenchymal stem cells. Cells Tissues Organs 2010;191: 443-452.
31. Lin J, Patel SR, Cheng X, et al. Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease. Nat Med 2005;11:387-393.
32. Topol LZ, Bardot B, Zhang Q, et al. Biosynthesis, post- Translation modification, and functional characterization of Drm/Gremlin. J Biol Chem 2000;275: 8785-8793.
33. Costello CM, Cahill E, Martin F, Gaine S, McLoughlin P. Role of gremlin in the lung: development and disease. Am J Respir Cell Mol Biol 2010;42:517- 523.
34. Chondronikola M, Volpi E, Børsheim E, et al. Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans. Diabetes 2014;63:4089-4099.
35. Jespersen NZ, Larsen TJ, Peijs L, et al. A classical brown adipose tissue mRNA signature partly overlaps with brite in the supraclavicular region of adult humans. Cell Metab 2013;17:798-805.
36. Waldén TB, Hansen IR, Timmons JA, Cannon B, Nedergaard J. Recruited vs. nonrecruited molecular signatures of brown, "brite, " and white adipose tissues. Am J Physiol Endocrinol Metab 2012;302:E19-E31.
37. Seale P, Conroe HM, Estall J, et al. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J Clin Invest 2011;121: 96-105.
38. Gustafson B, Smith U. Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. J Biol Chem 2006;281:9507-9516.
39. Du B, Cawthorn WP, Su A, et al. The transcription factor paired-related homeobox 1 (Prrx1) inhibits adipogenesis by activating transforming growth factor-b (TGFb) signaling. J Biol Chem 2013;288:3036-3047.
40. Ohgo S, Hasegawa S, Hasebe Y, Mizutani H, Nakata S, Akamatsu H. Bleomycin inhibits adipogenesis and accelerates fibrosis in the subcutaneous adipose layer through TGF-b1. Exp Dermatol 2013;22:769-771.
41. Wei J, Ghosh AK, Sargent JL, et al. PPARg downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: A novel mechanism for progressive fibrogenesis. PLoS ONE 2010;5:e13778.
42. Gupta RK, Mepani RJ, Kleiner S, et al. Zfp423 expression identifies committed preadipocytes and localizes to adipose endothelial and perivascular cells. Cell Metab 2012;15:230-239.
43. Whittle AJ, Carobbio S, Martins L, et al. BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell 2012;149: 871-885.
44. Lönn M, Mehlig K, Bengtsson C, Lissner L. Adipocyte size predicts incidence of type 2 diabetes in women. FASEB J 2010;24:326-331.
45. Cohen P, Levy JD, Zhang Y, et al. Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch. Cell 2014;156:304-316.
46. Qian SW, Tang Y, Li X, et al. BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis. Proc Natl Acad Sci U S A 2013;110:E798-E807.
47. Dahlman I, Elsen M, Tennagels N, et al. Functional annotation of the human fat cell secretome. Arch Physiol Biochem 2012;118:84-91.
48. Lee YH, Petkova AP, Mottillo EP, Granneman JG. In vivo identification of bipotential adipocyte progenitors recruited by b3- Adrenoceptor activation and high-fat feeding. Cell Metab 2012;15:480-491.
49. Wang QA, Tao C, Gupta RK, Scherer PE. Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat Med 2013;19: 1338-1344.